The FDA was aware of operational deficiencies at foreign plants responsible for producing infant formula, according to a report by Food Safety News. These facilities have been linked to a botulism outbreak spanning multiple states.
The revelations raise questions regarding oversight of international suppliers and the timing of regulatory interventions to protect infant health.
